Search research articles
Contact Us
Filters
Showing results (111-120 of 162) with videos related to
Page
of 17
Sort By:
The Journal of Investigative Dermatology
|
February 18, 2019
Molecular Genomic Profiling of Melanocytic Nevi
Andrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Journal of Translational Medicine
|
April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2019
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K <i>BRAF</i>-Mutant Melanoma
Inês Pires da Silva, Kevin Y X Wang, James S Wilmott, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W Conway, Robert V Rawson, Serigne Lo, et al.
Human Molecular Genetics
|
September 10, 2013
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis
Diego M Marzese, Richard A Scolyer, Jamie L Huynh, et al.
Journal for Immunotherapy of Cancer
|
April 27, 2024
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma
Judith M Versluis, Stephanie A Blankenstein, Petros Dimitriadis, et al.
Nature Communications
|
May 22, 2019
LNK suppresses interferon signaling in melanoma
Ling-Wen Ding, Qiao-Yang Sun, Jarem J Edwards, et al.
The Journal of Investigative Dermatology
|
September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma
Asmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Cancer Immunology Research
|
September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
Jarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G House, Peter Savas, Junyun Lai, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 162) with videos related to
Sort By:
Page
of 17
The Journal of Investigative Dermatology
|
February 18, 2019
Molecular Genomic Profiling of Melanocytic Nevi
Andrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Journal of Translational Medicine
|
April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2019
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K <i>BRAF</i>-Mutant Melanoma
Inês Pires da Silva, Kevin Y X Wang, James S Wilmott, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W Conway, Robert V Rawson, Serigne Lo, et al.
Human Molecular Genetics
|
September 10, 2013
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis
Diego M Marzese, Richard A Scolyer, Jamie L Huynh, et al.
Journal for Immunotherapy of Cancer
|
April 27, 2024
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma
Judith M Versluis, Stephanie A Blankenstein, Petros Dimitriadis, et al.
Nature Communications
|
May 22, 2019
LNK suppresses interferon signaling in melanoma
Ling-Wen Ding, Qiao-Yang Sun, Jarem J Edwards, et al.
The Journal of Investigative Dermatology
|
September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma
Asmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Cancer Immunology Research
|
September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
Jarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G House, Peter Savas, Junyun Lai, et al.
Page
of 17